Last reviewed · How we verify

NCT04252521

Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

Completed NA Last updated 8 February 2024
What this trial tests

NA trial testing metoclopramide in Migraine in 150 participants. Completed in 3 January 2020.

Timeline
3 July 2019
Primary endpoint
3 January 2020
3 January 2020

Quick facts

Lead sponsorAdiyaman University Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment150
Start date3 July 2019
Primary completion3 January 2020
Estimated completion3 January 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Adiyaman University Research Hospital

Who can join

Adults 18 to 100, any sex, with Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute headache is one of the most common reasons for presentation to the emergency department (ED), accounting for 2-3% of all emergency visits. Migraine is a disorder of the central nervous system characterized by a moderate or severe headache, which is generally associated with nausea and/or sensitivity to light and sound, interfering with daily activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of metoclopramide

Trials testing the same drug.

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other Adiyaman University Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04252521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing